On air · 1 of 3 networks
Genes MDPI
- mdpi.com
- Media, Events & Publishing
- CH
- 7 employees
Genes MDPI’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 48. Watch Genes MDPI with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| None recorded | 0 | Checked 28 Oct 2026 | See all 48 ads → | ||
| Meta | None recorded | 0 | No active ads recorded on the Meta Ad Library | Checked 21 Oct 2026 | Collect them with the API → |
| Running | 53 | Ads on the Google Ads Transparency Center | Checked 29 Oct 2026 | Collect them with the API → |
Genes MDPI has no live LinkedIn ads. Its Facebook page had no active ads on 21 Oct 2026, and we recorded 53 Google ads on 29 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 26 Mar 2026
Join us at the 3rd International Online Conference on Genes (#IOCGE2026), to be virtually held on 2–4 December 2026. Seize the chance to publish your work in a top-notch journal! Participants with accepted abstracts of IOCGE 2026 are granted TWO publication opportunities: 👉 Genes Journal Special Issue Submit your full manuscript to the special issue “Selected Papers from the 3rd International Online Conference on Genes (IOCGE 2026)”, published in Genes (ISSN: 2073-4425, IF 2.8), with a 10% discount on the publication fees. 👉Proceeding Paper Publication Submit a proceeding paper (4–8 pages) to the Biology and Life Sciences Forum Proceedings (ISSN: 2673-9976) after the conference, free of charge. All submitted papers will undergo MDPI's standard peer-review procedure. Important Dates 1️⃣ Abstract Submission Deadline: 4 August 2026 2️⃣ Proceedings Paper Submission Deadline: 18 January 2027 Submit your abstract TODAY: https://lnkd.in/eEYrSKrp #MDPIConference #openaccess #genes #IOCGE2026 #genetics #genomics #RNA #geneticdisorders #metagenomics #epigenetics #bioinformatics #pharmacogenomics #geneticepidemiology
- LINKEDIN · IMAGESince 20 Mar 2026
Review by Dr. Marta Pengo and Prof. Dr. Ferdinando Squitieri aimed to dissect the many faces of genetics in Huntington disease pathogenesis, from cis- and trans-acting genetic modifiers to RNA toxicity, mitochondrial DNA mutations, and epigenetics factors. You can read this Editor's choice review at: https://lnkd.in/eR6yAiEv
- LINKEDIN · IMAGESince 14 Mar 2026
Dr. David Alan Schwartz discusses the mechanisms and significance of development of novel reassortant strains of Oropouche virus and their recent recognition as causing vertical infection and adverse perinatal outcomes among pregnant women with Oropouche fever. Read this Editor's Choice paper at: https://lnkd.in/eQi5kR7P
- LINKEDIN · IMAGESince 5 Mar 2026
Review by Prof. Chenfang Wang, Dr. Jiangang Kang et al. aims to analyze the research progress of sexual reproduction, secreted proteins, and deoxynivalenol of 𝘍𝘶𝘴𝘢𝘳𝘪𝘶𝘮 𝘨𝘳𝘢𝘮𝘪𝘯𝘦𝘢𝘳𝘶𝘮, emphasizing the regulation of sexual reproduction and deoxynivalenol synthesis. Read this Editor's Choice review at: https://lnkd.in/esmwDXHs
- LINKEDIN · IMAGESince 3 Mar 2026
Dr. Minja Zorc, Mateja Dolinar and Prof. Dr. Peter Dovč from University of Ljubljana reported the application of scRNA-seq to elucidate the cell type repertoire in bovine milk based on the transcriptomic differences between different cell clusters. Read this Editor's Choice paper: https://lnkd.in/ewEEqM6t
- LINKEDIN · IMAGESince 27 Feb 2026
In their study, Dr. Hayato Tada and colleagues summarize the epidemiology of familial hypercholesterolemia based on numerous genetic studies, including its pathogenic variants, genotype–phenotype correlation, prognostic factors, screening, and usefulness of genetic counseling and genetic testing. Read this Editor's Choice review now: https://lnkd.in/e9Vtc9yu
6 of 48 adsSign up to see every Genes MDPI ad, filter by format and date, and get alerts on new ones.
See all 48 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.